SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

: Emerging Challenges in Primary Care 2018 Birmingham, AL
Activity/Course #:
: 05.19.18PC

: Free
Release/Start Date:
: May 19 2018
Expiration Date:
: May 19 2018
: Primary Care Medicine
Target Audience:
: Primary Care Providers
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 3.5 pharmacology hour(s)
Hardware/Software Requirements:
Saturday, May 19, 2018
The Westin Birmingham Hotel
2221 Richard Arrington Junior Boulevard North
Birmingham, AL 35203
(205) 307-3600

Registration Fee
There is no registration fee for this activity.

Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
A self-parking rate of $8.00 is available at the hotel - Lot 7.

Program Summary
Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.
Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives

  1. Recognize the pathogenesis of type 2 diabetes (T2DM) as a progressive, multi-defect disorder; Discuss the strengths and limitations of current guidelines for diabetes manager; Successfully use strategies for adherence to multiple medications to improve outcomes in diabetes; Examine data on current combination strategies to choose therapies that most effectively address a patient’s underlying pathophysiologic needs
  2. Discuss clinician and patient barriers to initiation and intensification of insulin therapy; Recognize the prevalence and clinical impact of hypoglycemia in special populations at risk; Discuss the pharmacology and clinical differences between existing and new long-acting and concentrated insulins; Discuss how to incorporate new basal and concentrated insulins into clinical practice while minimizing the risk of adverse events
  3. Review the risk factors and classification of pulmonary hypertension (PH); Discuss the appropriate diagnostic strategy for pulmonary arterial hypertension (PAH), including the roles of echocardiography, ventilation/perfusion (V/Q) scanning, and right heart catheterization (RHC); Review current and emerging treatments for patients with PAH; Describe how to monitor patients with PAH for disease progression
  4. Describe strategies of care in COPD to improve diagnosis and ongoing symptom assessment; Tailor COPD pharmacotherapy according to current guidelines while incorporating unique patient needs and characteristics; Discuss the appropriate use of inhaled therapies for COPD, including the importance of proper inhaler technique; Collaborate with members of interprofessional health care team for effective chronic disease management
  5. Review and characterize the clinical features of atopic dermatitis (AD); Discuss the current immuno-pathophysiology of AD; Identify strategies for comprehensive treatment of atopic dermatitis in pediatric and adult populations; Update and position emerging topical therapies as well as up and coming targeted biologic agents as a new treatment category for AD
  6. Identify and describe the clinical features of psoriatic skin and joint disease; Review and discuss associated comorbidities and emerging bio factors and their significance in the management of psoriatic disease; Discuss the expanding and dynamically changing treatment paradigm for psoriasis and its related disorders; Review and interpret up to date evidence-based clinical trial data and the latest treatments available for the management of psoriatic disease


 Continental Breakfast and Registration
 Welcome Remarks
Marlene Wolf, MD
 The Progression of Type 2 Diabetes: A Rational Approach for Long Term Disease Management
Rodolfo J. Galindo, MD
 Safely Achieving Goals in Type 2 Diabetes (T2DM):The Role of Concentrated and Long-Acting Insulins
Rodolfo J. Galindo, MD
 Evolving Strategies of Care in Pulmonary Arterial Hypertension: Integrating the Data into Practice
Arunabh Talwar, MD, FCCP
 The Evolving Landscape of COPD: Strategies to Optimize Care and Improve Outcomes
Arunabh Talwar, MD, FCCP
 Atopic Dermatitis: New Insights, New Therapies
Adelaide A. Hebert, MD
 3:30-4:40  Confronting Psoriatic Disease: Putting New Tools to Work
Adelaide A. Hebert, MD

Program Summary and Closing Remarks
Marlene Wolf, MD


*Agenda subject to change.


Rodolfo J. Galindo, MD
Assistant Professor of Medicine
Emory University School of Medicine
Principal Investigator, Center for Diabetes and Metabolism Research
Division of Endocrinology, Diabetes and Metabolism
Emory University Hospital Midtown
Medical Chair, Hospital Diabetes Taskforce
Emory Healthcare System
Atlanta, GA

Adelaide A. Hebert, MD
The University of Texas
Professor, Department of Dermatology
Director, Pediatric Dermatology
Houston, TX

Arunabh Talwar, MD, FCCP
Director, Pulmonary Hypertension and Advanced Lung Disease Program
North Shore University Hospital, Manhasset, New York
Professor Of Medicine
Hofstra Northwell School of Medicine
Hofstra University
Hempstead, NY

Marlene R. Wolf, MD, FAAFP
Clinical Assistant Professor of Family Medicine
Nova Southeastern University's College of Allopathic Medicine
Family Practice
Lifetime Medical Consulting, LLC
Coral Springs, FL

Planning Committee
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL

Sandy Bihlmeyer, M.Ed.
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education
Plantation, FL

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education
Plantation, FL

Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7 Contact hour(s) of continuing education which includes 3.5 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., an educational grant from Novo Nordisk Inc, an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals, and an educational grant from Lilly. For further information concerning Lilly grant funding visit